Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04264624
Other study ID # GBT2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2018
Est. completion date December 10, 2019

Study information

Verified date February 2020
Source Azienda Ospedaliera Spedali Civili di Brescia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The first step in the management of periodontal disease involves the non-surgical removal of the soft and hard bacterial deposits at all supra- and sub-gingival sites, especially into deep pockets, which can be carried on with different instruments. Unfortunately it seems that, after the initial therapy, many patients still present with active pockets (residual pockets) requiring further treatment and posing a risk of disease progression. This might be due to limitations of the instruments applied and patient-related factors. Air-polishing with low-abrasiveness powders seems to be very effective in the removal of supra- and sub-gingival biofilm and could provide additional benefits during the treatment of pockets.

The hypothesis of the present randomized controlled trial was that the adjunctive use of a sub-gingival nozzle for air-polishing with erythritol powder in pockets with probing depth of 5-9mm and with bleeding (experimental sites) can bring clinical and microbiological advantages during the active therapy of periodontal disease, and reduce the number of residual pockets.

To test this hypothesis, the patients, upon initial evaluation, were divided in 2 study groups:

1. The control group, undergoing a standard procedure involving air-polishing supra-gingivally and at healthy sub-gingival sites followed by debridement with an ultrasonic scaler at deep pathological pockets

2. The study group, undergoing the same procedure but with the additional use of a sub-gingival nozzle at deep pathological pockets.

The healing of the experimental sites and the prevalence of residual pockets will be evaluated at 3 months after the initial therapy and compared between the two groups.


Description:

OUTCOME

1. Primary outcome measure: 3-month change in the number of sites with probing depth (PD) 5-9 mm and positive to bleeding upon probing (BoP). Sites characterized by PD 5-9 mm and BoP+ will be therefore identified as "experimental sites".

2. Secondary outcomes: 3-month changes in the following clinical parameters assessed at experimental sites: clinical attachment level (CAL), PD, number of sites harboring supra-gingival plaque.

3. Other evaluations: Pocket microbiological (subgingival plaque) samples at one (interproximal) experimental site for analysis of periodontal pathogens at baseline and 3 months following treatment.

STUDY POPULATION Forty (40) adults, aged 18-75 years, will be entered into study (randomized). It is expected that at least thirty-two (32) subjects will complete the study.

Randomized subjects who deviate from the protocol (major protocol deviation) and, for this reason, are excluded from the analysis, will be replaced to guarantee that the sample required for the analysis (32) is reached.

Inclusion Characteristics

- Signed Informed Consent Form.

- Male and female subjects, aged 18-75 years, inclusive.

- Good general health (free of systemic diseases such as diabetes, HIV infection or genetic disorder, ongoing malignant disease of any type that could influence the outcome of the treatment and might interfere with the evaluation of the study objectives).

- Moderate to severe periodontitis

- At least 8 experimental sites (PD 5-9 mm and BoP+).

- Availability for the 3-month duration of the study for an assigned subject.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 10, 2019
Est. primary completion date October 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Signed Informed Consent Form.

- Male and female subjects, aged 18-75 years, inclusive.

- Good general health (free of systemic diseases such as diabetes, HIV infection or genetic disorder, ongoing malignant disease of any type that could influence the outcome of the treatment and might interfere with the evaluation of the study objectives).

- Moderate to severe periodontitis

- At least 8 experimental sites (PD 5-9 mm and BoP+).

- Availability for the 3-month duration of the study for an assigned subject.

Exclusion Criteria:

- Presence of orthodontic appliances.

- Chronic obstructive pulmonary disease and asthma.

- Tumors or significant pathology of the soft or hard tissues of the oral cavity.

- Current radiotherapy or chemotherapy.

- Pregnant or lactating women.

- Current or past (within 3 months prior to enrolment) assumption of medications that may influence periodontal conditions and/or interfere with healing following periodontal treatment (i.e., corticosteroids, calcium channel blockers, systemic antibiotics, ...).

- History of allergy to Erythritol.

- Restorations on the teeth to be treated which may interfere with treatment administration and/or scoring procedures, at the discretion of the examiner.

- Non-surgical and/or surgical mechanical/manual periodontal debridement within 3 months prior to enrolment.

- Use of systemically administered antibacterial agents to treat periodontal disease or dental prophylaxis within 3 months prior to enrolment.

Study Design


Intervention

Device:
Perioflow and Erythritol powder and ultrasonic debridement
Airflow and Perioflow combined with Erythritol powder will be used as an adjunct therapy
Airflow and Erythritol powder and ultrasonic debridement
Airflow combined with Erythritol powder will be used as an adjunct therapy

Locations

Country Name City State
Italy Magda Mensi Brescia Lombardia

Sponsors (2)

Lead Sponsor Collaborator
Azienda Ospedaliera Spedali Civili di Brescia Università degli Studi di Ferrara

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome measure:3 month and to the end of study ( 1 years) Sites characterized by PD 5-9 mm and BoP+ will be therefore identified as "experimental sites". through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05065034 - Effects of Antibiotic Therapy on the Short and Long-term Results of Periodontitis Treatments
Completed NCT05456555 - The Flapless Approach in Periodontal Regeneration N/A
Completed NCT03851757 - Cleansing Efficacy of Waist-shaped Interdental Brushes. N/A
Completed NCT04240015 - Association of Periodontitis With Oral Health Related Quality of Life
Completed NCT05724251 - Effect of Iodine Deficiency on Periodontitis
Completed NCT05730153 - Advanced Platelet-rich Fibrin Combined With Open Debridement in Management of Suprabony Periodontal Defects Phase 4
Recruiting NCT06426550 - Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV N/A
Not yet recruiting NCT06351722 - Non-surgical Periodontal Treatment in Smokers on SIRT-1, NLRP3 Inflammasome and LncRNAs
Recruiting NCT04149834 - Clinical and Radiographic Evaluation of NIPSA Versus M-MIST in Treatment of Intra-osseous Defects N/A
Completed NCT05466253 - Early Versus Delayed Orthodontic Treatment After Periodontal Surgery on Periodontal Health in Periodontally Compromised Patients N/A
Completed NCT04076098 - Locally Delivered Minocycline in Advanced Periodontitis Phase 4
Withdrawn NCT05646459 - Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients. Phase 1
Not yet recruiting NCT06469294 - Evaluation of Chlorhexidine Gel Associated With Photodynamic Therapy in the Treatment in Diabetic Participants N/A
Active, not recruiting NCT03297749 - Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome N/A
Completed NCT05015387 - Efficacy of Proanthocyanidins in Non-Surgical Periodontal Therapy Phase 2
Completed NCT06064799 - GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers Periodontitis Patients
Completed NCT03453476 - Effect of Photodynamic Therapy on Gingival Crevicular Cytokines in Periodontitis Patients N/A
Completed NCT03178838 - Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis N/A
Recruiting NCT03432975 - Evaluation of Multiple Subgingival Irrigations. N/A
Completed NCT05293301 - Utilization of a Periodontal Endoscope in Nonsurgical Periodontal Therapy N/A